Epidemiology and clinical features of Streptococcus pyogenes bloodstream infections in children in Madrid, Spain.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Jul 2023
Historique:
received: 30 01 2023
accepted: 31 03 2023
revised: 24 03 2023
medline: 21 7 2023
pubmed: 4 5 2023
entrez: 4 5 2023
Statut: ppublish

Résumé

Studies have shown increased invasive Group A Streptococcus (GAS) disease, including bloodstream infections (GAS-BSI). However, the epidemiological data of GAS-BSI are limited in children. We aimed to describe GAS-BSI in children in Madrid, over 13 years (2005-2017). Multicenter retrospective cohort study from 16 hospitals from Madrid, Spain. Epidemiology, symptomatology, laboratory, treatment, and outcome of GAS-BSI in children ≤ 16 years were analyzed. 109 cases of GAS-BSI were included, with incidence rate of 4.3 episodes/100,000 children attended at the emergency department/year. We compared incidence between two periods (P1: 2005-June 2011 vs P2: July 2011-2017) and observed a non-significant increase along the study period (annual percentage change: + 6.0% [95%CI: -2.7, + 15.4]; p = 0.163). Median age was 24.1 months (IQR: 14.0-53.7), peaking during the first four years of life (89/109 cases; 81.6%). Primary BSI (46.8%), skin and soft tissue (21.1%), and osteoarticular infections (18.3%) were the most common syndromes. We compared children with primary BSI with those with a known source and observed that the former had shorter hospital stay (7 vs. 13 days; p = 0.003) and received intravenous antibiotics less frequently (72.5% vs. 94.8%; p = 0.001) and for shorter duration of total antibiotic therapy (10 vs. 21 days; p = 0.001). 22% of cases required PICU admission. Factors associated with severity were respiratory distress, pneumonia, thrombocytopenia, and surgery, but in multivariate analysis, only respiratory distress remained significant (adjusted OR:9.23 [95%CI: 2.16-29.41]). Two children (1.8%) died.   Conclusion: We observed an increasing, although non-significant, trend of GAS-BSI incidence within the study. Younger children were more frequently involved, and primary BSI was the most common and less severe syndrome. PICU admission was frequent, being respiratory distress the main risk factor. What is known: • In recent decades, several reports have shown a worldwide increase in the incidence of invasive Group A streptococcal disease (GAS), including bloodstream infection (BSI). Recently, there have been a few reports showing an increase in severity as well. • There needs to be more information on the epidemiology in children since most studies predominantly include adults. What is new: • This study, carried out in children with GAS-BSI in Madrid, shows that GAS-BSI affects mostly younger children, with a broad spectrum of manifestations, needing PICU admission frequently. Respiratory distress was the leading risk factor for severity, whereas primary BSI seemed to be less severe. • We observed an increasing, although non-significant, trend of GAS-BSI incidence in recent years (2005-2017).

Identifiants

pubmed: 37140702
doi: 10.1007/s00431-023-04967-5
pii: 10.1007/s00431-023-04967-5
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3057-3062

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Tapiainen T, Launonen S, Renko M, Saxen H, Salo E, Korppy M, Kainulainen L, Heiskanenkosma T, Lindholm L, Vuopio J et al (2016) Invasive Group A Streptococcal Infections in Children: A Nationwide Survey in Finland. Pediatr Infect Dis J 35(2):123–128. https://doi.org/10.1097/INF.0000000000000945
doi: 10.1097/INF.0000000000000945 pubmed: 26440814
Espadas-Maciá D, Macián EMF, Borrás R, Poujois Gisbert S, Muñoz Bonet JI (2018) Streptococcus pyogenes infection in paediatrics: from pharyngotonsillitis to invasive infections. An Pediatr (Engl Ed) 88(2):75–81. https://doi.org/10.1016/j.anpedi.2017.02.011
doi: 10.1016/j.anpedi.2017.02.011 pubmed: 28366695
Centers for Disease Control and Prevention (CDC) (2022) Increase in invasive group A strep infections. Atlanta: CDC. Available from: https://www.cdc.gov/groupastrep/igasinfectionsinvestigation.html#:~:text=CDC%20is%20looking%20into%20a,and%20streptococcal%20toxic%20shock%20syndrome
Guy R, Henderson KL, Coelho J, Hughes H, Mason EL, Gerver SM, Demirjian A, Watson C, Sharp A, Brown CS, Lamagni T (2023) Increase in invasive group A streptococcal infection notifications, England, 2022. Euro Surveill.  https://doi.org/10.2807/1560-7917.ES.2023.28.1.2200942
Cobo-Vázquez E, Aguilera-Alonso D, Carrasco-Colom J, Calvo C, Saavedra-Lozano J, PedGAS-net Working Group (2023) Increasing incidence and severity of invasive group A streptococcal disease in Spanish children in 2019–2022. The Lancet Regional Health. Europe 27. https://doi.org/10.1016/j.lanepe.2023.100597
de Gier B, Marchal N, de Beer-Schuurman I, te Wierik M, Hooiveld M, de Melker HE, van Sorge NM, ISIS-AR Study Group, GAS Study group, Members of the ISIS-AR study group (2023) Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022. Euro Surveill 28(1):2200941. https://doi.org/10.2807/1560-7917.ES.2023.28.1.2200941
Suárez-Arrabal MC, Sánchez Cámara LA, Navarro Gómez ML, Santos Sebastián MDM, Hernández-Sampelayo T, Cercenado Mansilla E, Saavedra-Lozano J (2019) Invasive disease due to streptococcus pyogenes: changes in incidence and prognostic factors. An Pediatr 91(5):286–295. https://doi.org/10.1016/j.anpedi.2018.12.017
doi: 10.1016/j.anpedi.2018.12.017
Montes M, Ardanuy C, Tamayo E, Domènech A, Liñares J, Pérez-Trallero E (2011) Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998–2009): comparison with non-invasive isolates. Eur J Clin Microbiol Infect Dis 30(10):1295–1302. https://doi.org/10.1007/s10096-011-1226-x
doi: 10.1007/s10096-011-1226-x pubmed: 21491178
Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren ML, Lynfiedl R, Aragon D, Zansky SM, Watt JP, Cieslak PR et al (2016) Epidemiology of invasive group A streptococcal infections in the United States, 2005–2012. Clin Infect Dis 63(4):478–486. https://doi.org/10.1093/cid/ciw248
doi: 10.1093/cid/ciw248 pubmed: 27105747
Meehan M, Murchan S, Gavin PJ, Drew RJ, Cunney R (2018) Epidemiology of an upsurge of invasive group A Streptococcal infections in Ireland, 2012–2015. J Infect 77(3):183–190. https://doi.org/10.1016/j.jinf.2018.05.010
doi: 10.1016/j.jinf.2018.05.010 pubmed: 29935196
Ching NS, Crawford N, McMinn A, Baker C, Azzopardi K, Brownlee K, Lee D, Gibson M, Smeesters P, Gonis G et al (2017) Prospective surveillance of pediatric invasive group a Streptococcus infection. J Pediatric Infect Dis Soc 8(1):46–52. https://doi.org/10.1093/jpids/pix099
doi: 10.1093/jpids/pix099
Babiker A, Li X, Lay YL, Strich JR, Warner S, Sarzynski S, Dekker JP, Danner RL, Kadri SS (2021) Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. Lancet Infect Dis 21(5):697–710. https://doi.org/10.1016/S1473-3099(20)30523-5
doi: 10.1016/S1473-3099(20)30523-5 pubmed: 33333013

Auteurs

Elvira Cobo-Vázquez (E)

Department of Pediatrics, Hospital Universitario Fundación de Alcorcón, Servicio de Pediatría, Calle Budapest Nº1, 28922, Alcorcón, Madrid, Spain.
PhD Program in Medicine, Universidad Complutense de Madrid, Madrid, Spain.

David Aguilera-Alonso (D)

PhD Program in Medicine, Universidad Complutense de Madrid, Madrid, Spain. david.aguilera@salud.madrid.org.
Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital General Universitario Gregorio Marañón. CIBER de enfermedades infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Servicio de Pediatría, Calle de O'Donnell, Madrid, 28009, Madrid, Spain. david.aguilera@salud.madrid.org.

Tania Carbayo (T)

Department of Neonatology, Hospital Universitario, 12 de Octubre, Madrid, Spain.

Lucía M Figueroa-Ospina (LM)

Department of Pediatrics, Hospital General de Villalba, Villalba, Madrid, Spain.

Francisco Sanz-Santaeufemia (F)

Department of Pediatrics, Hospital Universitario Niño Jesús, Madrid, Spain.

Fernando Baquero-Artigao (F)

Department of Infectious Diseases and Tropical Pediatrics, Hospital Universitario La Paz and IdiPaz Foundation, Madrid, Spain.
RITIP, Translational Research Network in Pediatric Infectious Diseases, CIBER de enfermedades infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Universidad Autónoma, Madrid, Spain.

Carmen Vázquez-Ordoñez (C)

Department of Pediatrics, Hospital, Universitario Ramón y Cajal, Madrid, Spain.

Jaime Carrasco-Colom (J)

Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario La Moraleja, Madrid, Spain.
Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitari Son Espases, Palma de Mallorca, Spain.

Daniel Blázquez-Gamero (D)

Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitario 12 de Octubre, Instituto de Investigación Hospital 12 de Octubre (imas12). Universidad Complutense, RITIP, Madrid, Spain.

Beatriz Jiménez-Montero (B)

Department of Pediatrics, Hospital Clínico San Carlos, Madrid, Spain.

Carlos Grasa-Lozano (C)

Department of Infectious Diseases and Tropical Pediatrics, Hospital Universitario La Paz and IdiPaz Foundation, Madrid, Spain.
RITIP, Translational Research Network in Pediatric Infectious Diseases, CIBER de enfermedades infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Universidad Autónoma, Madrid, Spain.
Department of Pediatrics, Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain.

María José Cilleruelo (MJ)

Department of Pediatrics, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.

Ana Álvarez (A)

Department of Pediatrics, Hospital Universitario de Getafe, Getafe, Madrid, Spain.

Cristina Comín-Cabrera (C)

Department of Pediatrics, Hospital Universitario de Torrejón, Torrejón de Ardoz, Madrid, Spain.

María Penin (M)

Department of Pediatrics, Hospital, Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.

Emilia Cercenado (E)

Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.

Rut Del Valle (R)

Department of Pediatrics, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.

Miguel Ángel Roa (MÁ)

Department of Pediatrics, Hospital Universitario de Móstoles, Móstoles, Madrid, Spain.

Irene García-De Diego (IG)

Department of Pediatrics, Hospital Universitario del Tajo, Aranjuez, Madrid, Spain.

Cristina Calvo (C)

Department of Infectious Diseases and Tropical Pediatrics, Hospital Universitario La Paz and IdiPaz Foundation, Madrid, Spain.
RITIP, Translational Research Network in Pediatric Infectious Diseases, CIBER de enfermedades infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Universidad Autónoma, Madrid, Spain.

Jesús Saavedra-Lozano (J)

Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital General Universitario Gregorio Marañón, CIBER de enfermedades infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Universidad Complutense, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH